Krill Oil

Last Updated: September 28, 2022

Krill oil is a mixture of fatty acids high in EPA and DHA (fish oil fatty acids) in the form of phospholipids, mostly as phosphatidylcholine; it appears to be better absorbed than fish oil, may be more cardioprotective, and has some unique (unexplored) fat burning effects.

Krill Oil is most often used for.



Don't miss out on the latest research

1.

Sources and Composition

1.1

Sources

Euphausiacea (commonly called 'Krill', which refers to the entire Euphausiacea family but can come from the atlantic or pacific in which the species are referred to as superba and pacifica, respectively[1]) is a family of small sea creature (crustacean) which confers some dietary eicosapentanoic acid (EPA) and docosahexaenoic acid (DHA), the two fatty acids that are the active components of fish oil and can increase plasma levels of EPA and DHA.[2] Krill tends to have similar DHA content to oily fish with a slightly higher EPA content (per weight basis).[1] The krill itself does have a respectable and bioavailable protein content (11.9-15.4% total animal weight; lipids consist of 0.5-3.6% total weight[1] and 12-50% dry weight[3]), but the oil itself is not a protein supplement due to processing most amino acids out of the oil; nutritionally, krill is similar to shrimp.[1]

What tends to make krill unique from fish oil is the collection of fatty acids in the form of phospholipids rather than triglycerides, which is a phenomena that separates crustacean animals from fish in general;[1] while crustaceans have been reported to have up to 65% of total fatty acids bound as phospholipids[4] krill has been quantified in the 28-58% range.[5][6]

1.2

Composition

Krill oil fatty acids tend to be diacylglycerides (two fatty acids bound to a glycerol molecule) rather than triglycerides, and due to binding to a phosphatidic acid group at the final binding site the structure is a phospholipid in nature.[7]

Fish oil supplementation tends to be triglycerides while Lovaza (brand name) are ethyl esters.

Structurally, the fatty acids are bound in phospholipid form. While they confer the same benefits as the fatty acids, there are some differences in the absorption kinetics and the phospholipid itself may also be bioactive

The fatty acid breakdown of krill oil appears to be 26.1-30.7% saturated fatty acids, 24.2-25.9% monounsaturated fatty acids, and 34.1-48.5% omega-3 polyunsaturated fatty acids; the final 2.5% consists of omega-6 fatty acids.[8][1] The individual fatty acid breakdown of krill oil (not considering the structural form) is:

  • Eicosapentaenoic acid (EPA; 20:5 n3) at 19% (fish oil at 27%)[8]
  • Docosahexaenoic acid (DHA; 22:6 n3) at 10.9% (fish oil at 24%)[8]
  • Myristic acid (14:0) at 7.2% (fish oil at 3.2%)[8]
  • Palmitic acid (16:0) at 21.8% (fish oil at 7.8%)[8]
  • Stearic acid (18:0) at 1.3% (fish oil at 2.6%)[8]
  • Arachidonic acid (20:0) at less than 0.1% (fish oil at 0.6%)[8]
  • Behenic acid (22:0) at 0.2% (fish oil at 0.4%)[8]
  • 16:1 n7 at 5.4% (fish oil 3.9%)[8]
  • 18:1, with n5,7, and 9 collectively 18.3% (fish oil 6.1%)[8]
  • 18:3 n3 at 1.0% (fish oil at 0.5%)[8]
  • 18:4 n3 at 1.6% (fish oil at 1.9%)[8]

Krill oil is high in the two fatty acids commonly said to underlie the benefits of fish oil, although on a per weight basis they appear to be a tad lower than fish oil due to a higher percentage of saturated fats in krill oil; krill oil is low in omega-6 fatty acids and has a respectable monounsaturated fat content which is fairly balanced with the omega-3 and saturated content

Of these fatty acids, between 28-58% are bound as phospholipids[5][6] and appear to be mostly phosphatidylcholine (48[5] to 80%[9] of various combinations[10][11]), with some phosphatidylethanolamine (1.5-8%[12][5]) and phosphatidylglycerol (1%[5]); some studies reported a high (21-24%) unidentifiable component[5] which is possibly phosphatidylserine but not confirmed to be so. The overall phosphatidylcholine content has been calculated once to be 34+/-5g per 100g oil.[10] Phosphatidylinositol appears to be negligible.[12]

Some diglycerides are further bound to cholesterol (0.79-4.65% total lipids)[6] and krill oil has been confirmed to not be a source of sphingomyelin like calf brain is.[13][12]

Approximately a bit more than half of the fatty acids are bound in the form of phospholipids, with phosphatidylcholine being the most prominent one. Other phospholipids and variants of mono/diacylglycerol molecules are also present, but likely to play minor roles

Other components of krill oil that may also confer bioactivity include:

  • 66.1mg of cholesterol has been detected per 100g krill, which is about a third of shrimp but similar to other fish products.[1] Other estimates suggest a range of 17-76.3mg/g in the oil 62.1-72.6mg/100g in the krill itself.[1]
  • Astaxanthin content has been reported[14][15] which is half the 3R,3'R configuration[16][15] and may be esterified (up to 95% of astaxanthin.[16]) Total carotenoids reach 878-1016mcg/g of the oil[17][18] and both β-carotene and vitamin A are negligible (latter at 91mcg/g, former undetectable[17])
  • Vitamin E[19]
  • A novel flavonoid, reported to be similar to 6,8-di-c-glucosylluteolin (secondhand reports)[19][14]

There appear to be a phenolic and cholesterol content in krill oil as well, with the astaxanthin content of the oil likely being too low to matter as a supplement itself (ie. the benefits on the astaxanthin page may not apply to orally ingested krill oil)

Fluoride contamination is thought to be an issue with krill oil supplementation as the exoskeletal of krill is very high in naturally occurring fluoride (350mg/100g) and while the tissue is low, upon death fluoride may migrate from the exoskeleton into the meat (up to 9mg/100g has been reported) if the shell is not immediately removed.[1][20][21] This fluoride is well absorbed by mammals,[22] but isn't thought to be a concern with immediate removal of the exoskeleton as over 99% of fluoride is localized there.[20] It is uncertain how or if this is a concern to krill oil supplementation.

There is likely to be low risk of mercury in krill oil sourced EPA and DHA, mainly due to positive correlations between fish size and predatory status with mercury content (putting fish such as shark, albacore tuna, and swordfish high in mercury concentrations with prawn, herring, and small fish lower); however, this does not appear to be directly assessed.

There is a logical basis for worry about fluoride contamination, but the exact level of concern towards krill oil supplements is not known. This concern can be heavily alleviated by proper processing and handling practises of krill

1.3

Properties

Freezing of krill appears to reduce the phospholipid content by up to 15% after 30 days of storage following freezing with about half of the phospholipids being destroyed after 7 months.[6]

Due to the astaxanthin content, the fatty acids in krill oil appear to be more resistant to oxidation as astaxanthin appears to be destroyed sacrificially.[23]

2.

Pharmacokinetics

2.1

Bioavailability

When testing the bioavailability of various forms of fish oils, Krill oil appears to be the most well absorbed. In a study with 1680mg oils, Krill oil elicited an AUC of 80.03+/-34.71% compared to fish oil triglycerides of 59.78+/-36.75% and fish oil ethyl esters at 47.53+/-38.42% (33% better absorbed than fish oil, 68% better absorbed than ethyl esters).[7]

Krill oil appears to be better absorbed than fish oil and fish oil ethyl esters

2.2

Serum

Oral intake of krill oil (500mg krill oil conferring 90.5mg combined EPA/DHA) has been confirmed to increase plasma DHA and EPA, as well as the intermediate (docosapentaenoic acid) and arachidonic acid; similar to fish oil.[8]

3.

Neurology

3.1

Neuroprotection

Although not directly linked to Krill oil, it appears that supplemental DHA (3% of lipids) in the form of phospholipids (37.2% phosphatidylcholine and 36.6% lyso-PC) appears to have more antioxidative effects in the brains of rats injected with the toxin streptozotocin relative to DHA in triglyceride form (fish oil supplementation).[24]

May be more neuroprotective than fish oil supplementation on a gram per gram basis as assessed by its antioxidant effects

3.2

Endocannabinoids

2-arachidonoylglycerol is an endocannabinoid that is increased in obese subjects (alongside anandamide)[25][26][27] and can be induced during high fat animal feeding[28] yet appears to be reduced in obese subjects following consumption of 2g of krill oil (216mg EPA and 90mg DHA) for 4 weeks while anandamide is unaffected;[29] this reduction is also noted in rats.[28] These endocannabinoid molecules are derived from arachidonic acid, and the lowering of plasma arachidonic acid with fish oil fatty acids (EPA and DHA[30]) is thought to underlie the observed effects.

3.3

Memory and Learning

Krill oil is thought to confer memory promoting properties due to consisting of both fish oil fatty acids and phosphatidylcholine, both of which have individually been linked to a betterment of memory and learning; some authors suspect the astaxanthin content also plays a role[31] due to its individual anxiolytic[32] and cognitive enhancing properties.[33]

Phospholipids from krill have been noted to increased performance in a radial maze test in adult rats at 301-420mg/kg EPA+DHA associated with neurogenesis in the dentate gyrus of the hippocampus.[9] This study noted that 100mg/kg EPA+DHA was ineffective.[9] Elsewhere, adult rats of both sexes given krill oil at 1.25% of the diet for six weeks (200mg per rat, or 1,000-1,333mg/kg) noted a cognitive enhancing effect (as assessed by lever discrimination) with mixed antidepressive effects that did not outperform Imipramine.[31]

Krill oil is linked to an improvement in memory in adult rats without overt cognitive degeneration, but requires quite a high oral dose for this to occur with the human equivalence exceeding 160mg/kg bodyweight

3.4

PMS

Menstrual cramping appears to be associated with a release of arachidonic acid following the menstration-induced reduction in progesterone which triggers a flux of prostaglandins and leukotrienes in the uterus;[34] this increase causes localized production of COX-mediated metabolites of arachidonic acid (prostaglandin F2 and E2) which cause vasoconstriction and myometrial contractions that underlie cramping.[34] It is though that the fish oil fatty acids of EPA and DHA may reduce the physical symptoms of PMS via competing with arachidonic acid in producing less inflammatory prostaglandins.[35]

One study has assessed the effects of 2g Krill oil daily over 90 days in women with diagnosed PMS, and found that supplementation caused a time-dependent improvement in all measured symptoms (breast tenderness, bloating, stress, irritability, depression, weight gain, etc.) that outperformed the control of fish oil despite having similar EPA and DHA content.[36] This study noted that both fish oil and krill oil were effective on physical symptoms of bloating, cramping, and weight gain although only krill oil had neural benefit.[36]

Fish oil fatty acids in general are thought to alleviate some symptoms of PMS (mostly related to cramping), and while krill oil has once been noted to be effective in this regard it has also reduced neural symptoms of PMS such as irritability and outperformed fish oil

4.

Cardiovascular Health

4.1

Cardiac Tissue

Supplemental krill oil has been confirmed to increase the omega-3 content of cardiac tissue in rats and pretreatment of krill oil prior to myocardial infarction can reduce the subsequent cardiac hypertrophy; rehabilitative supplementation does not appear as effective.[37]

4.2

Triglycerides

It has been noted that krill oil supplementation (3,000mg) has roughly comparable effects on lipoproteins and triglycerides as fish oil (1,600mg), although this study noted null results with both interventions in otherwise healthy persons.[8] Similarly, supplementation of 2,000mg krill oil daily for 21 days during a 'Daniel Fast' (vegan, plant based diet[38][39]) failed to modify the diet-induced reduction in HDL-C in otherwise healthy persons.[40]

In hyperlipidemic persons, krill oil supplementation at 1,000-1,500mg daily for 90 days has been implicated in increasing HDL-C (42.76-43.92%) and reducing LDL-C (32.03-35.70%), total cholesterol (13.71-13.44%), and triglycerides (11.03-11.89%) with all benefits being slightly greater with 2-3g daily;[14] the improvement in HDL-C reached 59.64% and the reduction in LDL-C reached 39.15% at 3g daily, and all treatments greatly outperformed the reference drug of fish oil (3g daily).[14]

5.

Inflammation and Immunology

5.1

Joints

In a rat model of rheumatoid arthritis (collagen injections; 0.44% of the diet as EPA+DHA from krill oil said to correspond to 1.8g in humans) was able to reduce paw thickness and arthritic score to a level greater than fish oil at the same oral EPA+DHA dose.[41] No measured cytokines (IL-1α, IL-1β, IL-7, IL-10, IL-12p70, IL-13, IL-15, IL-17 and TGF-β) appeared to be altered.[41]

When tested in humans, supplementation of krill oil at 300mg daily for 30 days was able to significantly improve WOMAC ratings in the range of 20.3-28.9% (depending on subscale) in persons with rheumatoid arthritis.[42]

May confer benefit to rheumatoid arthritis based on the animal research, which is a mechanism shared with fish oil. It appears to be better than fish oil, but this may simply be due to better absorption (and the difference becoming insignificant with higher fish oil intake relative to krill oil)

6.

Interactions with Glucose Metabolism

6.1

Interventions

Feeding rats a high fat diet paired with or without 2.5% krill oil is able to attenuate, but not abolish, the increases in glucose while effectively preventing the increase in insulin from occurring[43] which has been noted elsewhere in rats on a high fat fed diet[44] with a bit more efficacy in oil with a higher polyunsaturated fat (PUFA) and phospholipid content.[45]

7.

Interactions with Organ Systems

7.1

Liver

Krill oil has been noted to have differential effects relative to fish oil in the liver, where after supplementation of the diet with either krill oil (1.5%) or fish oil (1.1%) with similar EPA+DHA concentrations (0.29-0.31%) noted that Krill oil was able to activate 4,892 analyzed genes (20,118 assessed overall) whereas fish oil activated 192.[46] Both treatments seem to suppress hepatic glucose production, but only krill oil suppressed lipogenic genes (SREBF1, MLXIPL) while the increase in activity of the cholesterol biosynthesis pathway was noted to be a decrease with krill oil.[46] Elsewhere, krill oil has been noted to increase β-oxidation of fatty acids whereas fish oil is ineffective.[47]

There is evidence for different effects between Krill oil and fish oil on the liver that extend beyond merely being a better absorbed form of the fatty acids.

When a high fat diet is paired with 2.5% krill oil in rats, the increase in overall weight gain and liver weight gain is abolished (1.25% merely attenuates[44]) which is thought to be secondary to a reduction (55%) of citrate influx into the mitochondria and subsequent fatty acid synthesis (related to less Vmax of the transporter) and increase in hepatic fat oxidation (3.4-fold more than high fat control, 2.1-fold more than normal control).[43] This reduced rate of the tricarboxylate transporter has been noted elsewhere, which resulted in a decrease in lipogenesis in the liver.[48]

In animals, krill oil has been demonstrated to reduce liver fat accumulation during overfeeding via reducing the rate of a transporter involved in lipogenesis. It appears to do so to a degree greater than fish oil even when fatty acids (EPA and DHA) are controlled

7.2

Intestines

5% krill oil in the diet of rats given chemical-induced ulcerative colitis (via dextran sulfate sodium) was able to confer protective effects which were thought to be secondary to reducing inflammatory events.[49]

May be of use against ulcerative colitis; has not been directly compared against fish oil (to assess comparative potency)

References
2.^Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TMKrill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and womenNutr Res.(2009 Sep)
3.^Saether O, Ellingsen TE, Mohr VLipids of North Atlantic krillJ Lipid Res.(1986 Mar)
8.^Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JIMetabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteersLipids.(2011 Jan)
14.^Bunea R, El Farrah K, Deutsch LEvaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemiaAltern Med Rev.(2004 Dec)
15.^Moretti VM, Mentasti T, Bellagamba F, Luzzana U, Caprino F, Turchini GM, Giani I, Valfrè FDetermination of astaxanthin stereoisomers and colour attributes in flesh of rainbow trout (Oncorhynchus mykiss) as a tool to distinguish the dietary pigmentation sourceFood Addit Contam.(2006 Nov)
17.^BATHAM E, FISHER LR, HENRY KM, KON SK, THOMPSON SYPerformed vitamin A in marine CrustaceaBiochem J.(1951 Jan)
19.^[No authors listedKrill oil. MonographAltern Med Rev.(2010 Apr)
22.^Tenuta-Filho A, Alvarenga RCReduction of the bioavailability of fluoride from Antarctic krill by calciumInt J Food Sci Nutr.(1999 Jul)
24.^Hiratsuka S, Ishihara K, Kitagawa T, Wada S, Yokogoshi HEffect of dietary docosahexaenoic acid connecting phospholipids on the lipid peroxidation of the brain in miceJ Nutr Sci Vitaminol (Tokyo).(2008 Dec)
25.^Sipe JC, Scott TM, Murray S, Harismendy O, Simon GM, Cravatt BF, Waalen JBiomarkers of endocannabinoid system activation in severe obesityPLoS One.(2010 Jan 20)
26.^Di Marzo V, Côté M, Matias I, Lemieux I, Arsenault BJ, Cartier A, Piscitelli F, Petrosino S, Alméras N, Després JPChanges in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factorsDiabetologia.(2009 Feb)
27.^Annuzzi G, Piscitelli F, Di Marino L, Patti L, Giacco R, Costabile G, Bozzetto L, Riccardi G, Verde R, Petrosino S, Rivellese AA, Di Marzo VDifferential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patientsLipids Health Dis.(2010 Apr 28)
28.^Piscitelli F, Carta G, Bisogno T, Murru E, Cordeddu L, Berge K, Tandy S, Cohn JS, Griinari M, Banni S, Di Marzo VEffect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed miceNutr Metab (Lond).(2011 Jul 13)
29.^Banni S, Carta G, Murru E, Cordeddu L, Giordano E, Sirigu AR, Berge K, Vik H, Maki KC, Di Marzo V, Griinari MKrill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjectsNutr Metab (Lond).(2011 Jan 30)
31.^Wibrand K, Berge K, Messaoudi M, Duffaud A, Panja D, Bramham CR, Burri LEnhanced cognitive function and antidepressant-like effects after krill oil supplementation in ratsLipids Health Dis.(2013 Jan 25)
32.^Nishioka Y, Oyagi A, Tsuruma K, Shimazawa M, Ishibashi T, Hara HThe antianxiety-like effect of astaxanthin extracted from Paracoccus carotinifaciensBiofactors.(2011 Jan-Feb)
35.^Priddy AR, Killick SREicosanoids and ovulationProstaglandins Leukot Essent Fatty Acids.(1993 Nov)
36.^Sampalis F, Bunea R, Pelland MF, Kowalski O, Duguet N, Dupuis SEvaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrheaAltern Med Rev.(2003 May)
37.^Fosshaug LE, Berge RK, Beitnes JO, Berge K, Vik H, Aukrust P, Gullestad L, Vinge LE, Øie EKrill oil attenuates left ventricular dilatation after myocardial infarction in ratsLipids Health Dis.(2011 Dec 29)
38.^Bloomer RJ, Kabir MM, Canale RE, Trepanowski JF, Marshall KE, Farney TM, Hammond KGEffect of a 21 day Daniel Fast on metabolic and cardiovascular disease risk factors in men and womenLipids Health Dis.(2010 Sep 3)
39.^Bloomer RJ, Kabir MM, Trepanowski JF, Canale RE, Farney TMA 21 day Daniel Fast improves selected biomarkers of antioxidant status and oxidative stress in men and womenNutr Metab (Lond).(2011 Mar 18)
41.^Ierna M, Kerr A, Scales H, Berge K, Griinari MSupplementation of diet with krill oil protects against experimental rheumatoid arthritisBMC Musculoskelet Disord.(2010 Jun 29)
43.^Ferramosca A, Conte A, Burri L, Berge K, De Nuccio F, Giudetti AM, Zara VA krill oil supplemented diet suppresses hepatic steatosis in high-fat fed ratsPLoS One.(2012)
44.^Tandy S, Chung RW, Wat E, Kamili A, Berge K, Griinari M, Cohn JSDietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed miceJ Agric Food Chem.(2009 Oct 14)
45.^Li DM, Zhou DY, Zhu BW, Chi YL, Sun LM, Dong XP, Qin L, Qiao WZ, Murata YEffects of krill oil intake on plasma cholesterol and glucose levels in rats fed a high-cholesterol dietJ Sci Food Agric.(2013 Jan 26)
46.^Burri L, Berge K, Wibrand K, Berge RK, Barger JLDifferential effects of krill oil and fish oil on the hepatic transcriptome in miceFront Genet.(2011)
47.^Vigerust NF, Bjørndal B, Bohov P, Brattelid T, Svardal A, Berge RKKrill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-Eur J Nutr.(2012 Aug 25)
49.^Grimstad T, Bjørndal B, Cacabelos D, Aasprong OG, Janssen EA, Omdal R, Svardal A, Hausken T, Bohov P, Portero-Otin M, Pamplona R, Berge RKDietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in ratsScand J Gastroenterol.(2012 Jan)